Lisaftoclax (Bcl-2/Bcl-xl inhibitor 1) is an oral dual inhibitor of Bcl-2 and Bcl-xl, with IC50 values of 2 nM and 5.9 nM for Bcl-2 and Bcl-xl, respectively. Lisaftoclax is used to treat chronic lymphocytic leukemia (CLL) by inhibiting the action of the
Molecular Weight:
882.42
CAS Number:
[2180923-05-9]
Formula:
C45H48ClN7O8S
Target:
BCL
* VAT and and shipping costs not included. Errors and price changes excepted